Search PubMed⌕ Search

Biomedical subjects

T F Warner

Publications and source records attributed to T F Warner.

At least 109 records · Page 6Linked to original sources
PubMed1979

Effect of plant lectins on murine myeloma cells.

The mitogenic response (determined by uptake of [3H]-thymidine) of two different BALB/c myeloma lines, normal BALB/c spleen cells and spleen cells from tumour-bearing mice in primary culture to PHA, Con A, PWM and Robinia pseudoaccacia (RPA) extract was determined by measuring the uptake of [3H]-thymidine over 96 h. The pattern of the response of tumour and tumour-spleen cells to the 4 different lectins was similar, and different from that of normal spleen cells. The unstimulated cultures of tumour and tumour-spleen cells displayed an initial increased uptake of [3H]-thymidine, whereas stimulated cultures displayed a low initial uptake of label. After an initial phase of inhibition, ADJ-PC5 myeloma cells were stimulated by PHA and PWM to a greater extent than were normal spleen cells. On the other hand, normal spleen cells gave a markedly better response to Con A and RPA. The mitogenic response of tumour-spleen cells to all 4 lectins was intermediate between those observed for tumour and normal spleen cells; they responded better to Con A and RPA than did tumour cells but were not as responsive as spleen cells, whereas the converse was true for their response to PWM and PHA. In agreement with other reports, the data suggest that the responsiveness of tumour-spleen cells was due to the presence of tumour cells in this tissue. These results indicate that there is no definite evidence of an impaired lectin-responsiveness in lymphoid cells of mice bearing a myeloma.

Animals↗
PubMed1978

Circulating lymphocytes and the spread of myeloma. Review of the evidence.

Patients with myeloma harbour circulating lymphocytes which bear the idiotypic determinants (SIg-id+ cells) of their own myeloma protein. Circulating white cells with abnormal karyotypes have been found in other patients with this disease. SIg-id+ lymphocytes have also been identified in the peripheral blood of myeloma-tumour-bearing mice. Murine myelomas have been propagated in vivo from circulating mononuclear cells that possessed myeloma-tumour-associated antigens. This and other evidence reviewed here points strongly to the involvement of circulating lymphocyte-like stem cells in the spread of human myeloma.

Animals↗
PubMed1978

Carcinoid tumour of the uterine cervix.

A carcinoid tumour of the cervix in a 64-year-old woman is described. It is the first time that this rare tumour has been associated with carcinoma-in-situ.

Carcinoid Tumor↗
PubMed1978

Perineural angiogenesis in mice bearing subcutaneous tumours.

Cells of myeloma or fibrosarcoma were inoculated s.c. into BALB/c mice. Intact skins and tissue sections from animals killed at periodic intervals after inoculation of tumor cells were examined macroscopically and microscopically. The development of new blood vessels, probably involved in vascularization of the tumor, was observed around the nerves adjacent to the deposit of tumour cells. This occurred 5 days after inoculation of cells and before the tumour had a mean diameter of less than 1 mm. Lesser degrees of "perineural angiogenesis" were noted after s.c. inoculation of mineral oil, Freund's complete adjuvant or implantation of intact spleen, but none was observed with killed tumour cells.

Animals↗
PubMed1977

Circulating tumor cells in murine myeloma.

BALB/c mice bearing subcutaneous ADJ-PC5 myelomas had hematologic findings suggestive of a preleukemic syndrome: thrombocytopenia, anemia, leukocytosis, and megakaryocytic hyperplasia. Six BALB/c myelomas were successfully transplanted sc by fragments or cell suspensions of spleens from mice bearing a subcutaneous tumor, though typical myeloma cells were difficult to visualize by light microscopy in these spleens. The fidelity of transmission of the ADJ-PC5 myeloma by this procedure was shown by the retention of idiotypic specificity of the immunoglobulin produced by the tumor in a radioimmunoassay. The tumorigenic cell that homed to the spleen was apparent as early as 8 days after sc transplantation of the myeloma. The spleens of tumor-bearing mice, however, could destroy or suppress the expansion or growth of a limited number of cells that had migrated to the spleens. Tumorigenic cells present in the peripheral circulation constituted 2-3% of the leukocytes. These cells, however, had reduced levels of the murine myeloma viral and cell-associated antigens, were difficult to detect by an indirect immunofluorescence assay, and did not rapidly divide in this environment, as indicated by the very low number of cells detected by autoradiography.

Animals↗
PubMed1975

Kaposi's sarcoma: a byproduct of tumour rejection.

It is suggested that Kaposi's sarcoma is the result of a chronic immunological reaction between antigenically altered or transformed lymphoid cells and normal lymphocytes. In the course of this local graft-versus-host type activity, an angiogenesis factor is liberated and intense proliferation of mesenchymal and endothelial cells ensues. During the G.V.H.-like activity, an oncogenic virus is either transferred to or induced in the cells responsive to the angiogenesis factor. Thus, the stage is set for neoplastic transformation of these cells in an environment which is conducive to the progressive growth of the virally transformed vasoformative mesenchyme.

Angiogenesis Inducing Agents↗
PubMed1975

Regeneration of intact spleen in a heterotropic site in splenectomized mice.

The regeneration of intact spleens implanted in the sacrospinal areas of splenectomized mice was studied by light microscopy. The weight of the implanted tissue was not fully regenerated 50 days after implantation. The pattern of embryonic development of the spleen was investigated and the histologic appearance of the implant 46 days after implantation resembled that of normal spleen. The appearance of primitive myelopoietic stem in cells in the early phases of regeneration makes this an attractive model in which to study the biologic effects of tumour viruses.

Animals↗